National Cardiogenic Shock Initiative (CSI) Protocol

Sites participating in the National Cardiogenic Shock Initiative (CSI) have adopted the National CSI algorithm as the foundatio...

Using Impella 5.5® with SmartAssist® for Nonischemic Cardiomyopathy

IMP-1800...

Published Investigator-led Studies for AMI Cardiogenic Shock

IMP-1524...

Large Intracardiac Thrombus in COVID-19 Patient Managed with Percutaneous Thrombectomy and Right Ventricular Support

IMP-1432 v2...

CRT 2020 Cardiogenic Shock Overview: Understanding Recent Clinical Data

For Best Outcomes in AMI Cardiogenic Shock, Place Impella 2.5® or Impella CP® Pre-PCI

A preponderance of evidence from the FDA cVAD Study, Impella Quality Assurance Database and physician-initiated National Cardio...

Impella RP® Heart Pump Patient Selection Criteria Checklist

Use this checklist to guide treatment decisions and determine if the Impella RP is right for your patients. IMP-796 v3...

Dr. O’Neill’s IQ Data and AMICS Presentation from TCT 2018

Adoption of best practices improves survival for patients with Acute Myocardial Infarction and Cardiogenic Shock (AMICS) suppor...

Step-by-Step Guide to Left Heart Unloading with Impella 5.0®

The Impella 5.0 is approved for use in cardiogenic shock, and is proven to unload the left ventricle and support the systemic c...

Step-by-Step Guide to Right Heart Unloading with Impella RP®

The Impella RP is the only FDA approved support device for the treatment of right heart failure....

Abiomed’s Cardiogenic Shock Guidelines

The use of standardized protocols has been associated with improvement in outcomes for people in...

Cardiogenic Shock Clinical Dossier

Impella 2.5®, Impella CP®, Impella 5.0®, and Impella LD® heart pumps are now  FDA i...